Clinical Trial: A Prospective Observational Study on the Concordance Between 3D-bioprinted Patient-derived Tumor Avatar (3D-PTA) Drug Sensitivity Testing and Clinical Efficacy in Gastric Cancer (China)

Posted On: 2026-10-15

China, Oct. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Observational Study on the Concordance Between 3D-bioprinted Patient-derived Tumor Avatar (3D-PTA) Drug Sensitivity Testing and Clinical Efficacy in Gastric Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134437

Registration Time: 2026/10/14

Type: Observational study

Primary Sponsor: Peking University International Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343474

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective Observational Study on the Concordance Between 3D-bioprinted Patient-derived Tumor Avatar (3D-PTA) Drug Sensitivity Testing and Clinical Efficacy in Gastric Cancer (China)